133 related articles for article (PubMed ID: 35760010)
1. CLDN4 promotes growth of acute myeloid leukemia cells via regulating AKT and ERK1/2 signaling.
Hao S; Yang C; Song P; Shi H; Zou Y; Chen M; Wu X; Yin Y; Yu Z; Zhu W; Li M
Biochem Biophys Res Commun; 2022 Sep; 619():137-143. PubMed ID: 35760010
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.
Lin X; Shang X; Manorek G; Howell SB
PLoS One; 2013; 8(6):e67496. PubMed ID: 23805314
[TBL] [Abstract][Full Text] [Related]
3. CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway.
Luo J; Wang H; Chen H; Gan G; Zheng Y
Exp Physiol; 2020 Jun; 105(6):979-988. PubMed ID: 31856376
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
[TBL] [Abstract][Full Text] [Related]
5. Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β.
Murakami-Nishimagi Y; Sugimoto K; Kobayashi M; Tachibana K; Kojima M; Okano M; Hashimoto Y; Saji S; Ohtake T; Chiba H
Breast Cancer Res; 2023 Apr; 25(1):41. PubMed ID: 37059993
[TBL] [Abstract][Full Text] [Related]
6. Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin.
Shang X; Lin X; Howell SB
Cell Commun Signal; 2014 Oct; 12():59. PubMed ID: 25344320
[TBL] [Abstract][Full Text] [Related]
7. UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation.
Wang L; Zhao S; Wang Y; Liu J; Wang X
BMC Cancer; 2024 Apr; 24(1):497. PubMed ID: 38637730
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2.
Huang J; Xiao R; Wang X; Khadka B; Fang Z; Yu M; Zhang L; Wu J; Liu J
Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34476495
[TBL] [Abstract][Full Text] [Related]
9. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway.
Wang F; Yang L; Xiao M; Zhang Z; Shen J; Anuchapreeda S; Tima S; Chiampanichayakul S; Xiao Z
Sci Rep; 2022 Jul; 12(1):11444. PubMed ID: 35794161
[TBL] [Abstract][Full Text] [Related]
11. Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of K
Lowinus T; Heidel FH; Bose T; Nimmagadda SC; Schnöder T; Cammann C; Schmitz I; Seifert U; Fischer T; Schraven B; Bommhardt U
Cell Commun Signal; 2019 Jan; 17(1):5. PubMed ID: 30651113
[TBL] [Abstract][Full Text] [Related]
12. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
Yu K; Wang J; Hou J; Zhang L; Liang H
Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
[TBL] [Abstract][Full Text] [Related]
13. ACER3 supports development of acute myeloid leukemia.
Chen C; Yin Y; Li C; Chen J; Xie J; Lu Z; Li M; Wang Y; Zhang CC
Biochem Biophys Res Commun; 2016 Sep; 478(1):33-38. PubMed ID: 27470583
[TBL] [Abstract][Full Text] [Related]
14. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
15. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.
Doepfner KT; Spertini O; Arcaro A
Leukemia; 2007 Sep; 21(9):1921-30. PubMed ID: 17581609
[TBL] [Abstract][Full Text] [Related]
16. IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia.
Chapuis N; Park S; Leotoing L; Tamburini J; Verdier F; Bardet V; Green AS; Willems L; Agou F; Ifrah N; Dreyfus F; Bismuth G; Baud V; Lacombe C; Mayeux P; Bouscary D
Blood; 2010 Nov; 116(20):4240-50. PubMed ID: 20671123
[TBL] [Abstract][Full Text] [Related]
17. The E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in FLT3-ITD-positive MV4-11 AML cells.
Schnetzke U; Fischer M; Kuhn AK; Spies-Weisshart B; Zirm E; Hochhaus A; Müller JP; Scholl S
J Cancer Res Clin Oncol; 2013 Apr; 139(4):605-15. PubMed ID: 23263202
[TBL] [Abstract][Full Text] [Related]
18. Visfatin promotes the malignancy of human acute myeloid leukemia cells via regulation of IL-17.
Hui Z; Liu Z; He A; Chen Y; Zhang P; Lei B; Yao H; Yu Y; Liang R; Li Z; Zhang W
Eur J Pharmacol; 2019 Jun; 853():103-110. PubMed ID: 30876976
[TBL] [Abstract][Full Text] [Related]
19. Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways.
Li Q; Huai L; Zhang C; Wang C; Jia Y; Chen Y; Yu P; Wang H; Rao Q; Wang M; Wang J
Int J Hematol; 2013 May; 97(5):617-23. PubMed ID: 23550021
[TBL] [Abstract][Full Text] [Related]
20.
Zhao J; Liu J; Liu S; Tian S; Yuan H; Li S
Epigenomics; 2023 Mar; 15(6):369-383. PubMed ID: 37212125
[No Abstract] [Full Text] [Related]
[Next] [New Search]